Annual Total Assets
$13.66 B
-$456.59 M-3.23%
01 December 2023
Summary:
Sinovac Biotech annual total assets is currently $13.66 billion, with the most recent change of -$456.59 million (-3.23%) on 01 December 2023. During the last 3 years, it has risen by +$11.76 billion (+618.34%). SVA annual total assets is now -18.45% below its all-time high of $16.75 billion, reached on 31 December 2021.SVA Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$12.90 B
-$761.04 M-5.57%
01 June 2024
Summary:
Sinovac Biotech quarterly total assets is currently $12.90 billion, with the most recent change of -$761.04 million (-5.57%) on 01 June 2024. Over the past year, it has dropped by -$761.04 million (-5.57%). SVA quarterly total assets is now -22.99% below its all-time high of $16.75 billion, reached on 31 December 2021.SVA Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -5.6% |
| 3 y3 years | +618.3% | +2.1% |
| 5 y5 years | +3593.5% | +3040.6% |
SVA Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.4% | +618.3% | -23.0% | +2.1% |
| 5 y | 5 years | -18.4% | +3593.5% | -23.0% | +3040.6% |
| alltime | all time | -18.4% | >+9999.0% | -23.0% | >+9999.0% |
Sinovac Biotech Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $12.90 B(-5.6%) |
| Dec 2023 | $13.66 B(-3.2%) | $13.66 B(-0.5%) |
| June 2023 | - | $13.73 B(-2.8%) |
| Dec 2022 | $14.11 B(-15.7%) | $14.11 B(-6.3%) |
| June 2022 | - | $15.07 B(-10.0%) |
| Dec 2021 | $16.75 B(+780.9%) | $16.75 B(+32.6%) |
| June 2021 | - | $12.63 B(+564.2%) |
| Dec 2020 | $1.90 B(+320.4%) | $1.90 B(+188.7%) |
| Sept 2020 | - | $658.55 M(+24.4%) |
| June 2020 | - | $529.37 M(+22.2%) |
| Mar 2020 | - | $433.32 M(-4.2%) |
| Dec 2019 | $452.30 M(+22.3%) | $452.30 M(+10.1%) |
| Sept 2019 | - | $410.65 M(+1.7%) |
| June 2019 | - | $403.83 M(+5.8%) |
| Mar 2019 | - | $381.85 M(+3.3%) |
| Dec 2018 | $369.78 M(+23.6%) | $369.78 M(+20.2%) |
| June 2018 | - | $307.67 M(+2.8%) |
| Dec 2017 | $299.22 M(+41.6%) | $299.22 M(+21.9%) |
| June 2017 | - | $245.43 M(+16.1%) |
| Dec 2016 | $211.35 M(+4.2%) | $211.35 M(+3.7%) |
| Sept 2016 | - | $203.72 M(+12.3%) |
| June 2016 | - | $181.43 M(-11.3%) |
| Mar 2016 | - | $204.51 M(+0.8%) |
| Dec 2015 | $202.93 M(-14.9%) | $202.93 M(-0.7%) |
| Sept 2015 | - | $204.33 M(-6.1%) |
| June 2015 | - | $217.71 M(+2.5%) |
| Mar 2015 | - | $212.46 M(-10.9%) |
| Dec 2014 | $238.53 M(-0.9%) | $238.53 M(-1.6%) |
| Sept 2014 | - | $242.34 M(+5.1%) |
| June 2014 | - | $230.60 M(-3.3%) |
| Mar 2014 | - | $238.43 M(-0.9%) |
| Dec 2013 | $240.69 M(+15.3%) | $240.69 M(+6.7%) |
| Sept 2013 | - | $225.60 M(+1.3%) |
| June 2013 | - | $222.63 M(+3.2%) |
| Mar 2013 | - | $215.78 M(+3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $208.76 M(-3.3%) | $208.76 M(-0.6%) |
| Sept 2012 | - | $209.96 M(-0.5%) |
| June 2012 | - | $210.97 M(+0.7%) |
| Mar 2012 | - | $209.41 M(-3.0%) |
| Dec 2011 | $215.91 M(+0.7%) | $215.91 M(+4.2%) |
| Sept 2011 | - | $207.28 M(+2.6%) |
| June 2011 | - | $202.12 M(-0.6%) |
| Mar 2011 | - | $203.37 M(-5.1%) |
| Dec 2010 | $214.36 M(+47.3%) | $214.36 M(-1.9%) |
| Sept 2010 | - | $218.59 M(+5.2%) |
| June 2010 | - | $207.87 M(-7.6%) |
| Mar 2010 | - | $224.91 M(+54.6%) |
| Dec 2009 | $145.48 M(+74.8%) | $145.48 M(+16.9%) |
| Sept 2009 | - | $124.46 M(+6.5%) |
| June 2009 | - | $116.81 M(+44.3%) |
| Mar 2009 | - | $80.94 M(-2.7%) |
| Dec 2008 | $83.20 M(+44.8%) | $83.20 M(+7.4%) |
| Sept 2008 | - | $77.44 M(-2.1%) |
| June 2008 | - | $79.09 M(+13.8%) |
| Mar 2008 | - | $69.50 M(+21.0%) |
| Dec 2007 | $57.45 M(+55.2%) | $57.45 M(+9.8%) |
| Sept 2007 | - | $52.32 M(+16.7%) |
| June 2007 | - | $44.85 M(+21.2%) |
| Dec 2006 | $37.01 M(+18.2%) | $37.01 M(+16.4%) |
| June 2006 | - | $31.79 M(+1.6%) |
| Dec 2005 | $31.30 M(+39.6%) | $31.30 M(+31.6%) |
| June 2005 | - | $23.78 M(+6.0%) |
| Dec 2004 | $22.42 M(+50.5%) | $22.42 M(-3.1%) |
| Sept 2004 | - | $23.13 M(+0.2%) |
| June 2004 | - | $23.08 M(+54.9%) |
| Dec 2003 | $14.90 M(+6204.6%) | $14.90 M |
| Apr 2002 | $236.30 K(-12.2%) | - |
| Apr 2001 | $269.20 K(+21.5%) | - |
| Apr 2000 | $221.50 K(+561.2%) | - |
| Apr 1999 | $33.50 K | - |
FAQ
- What is Sinovac Biotech annual total assets?
- What is the all time high annual total assets for Sinovac Biotech?
- What is Sinovac Biotech quarterly total assets?
- What is the all time high quarterly total assets for Sinovac Biotech?
- What is Sinovac Biotech quarterly total assets year-on-year change?
What is Sinovac Biotech annual total assets?
The current annual total assets of SVA is $13.66 B
What is the all time high annual total assets for Sinovac Biotech?
Sinovac Biotech all-time high annual total assets is $16.75 B
What is Sinovac Biotech quarterly total assets?
The current quarterly total assets of SVA is $12.90 B
What is the all time high quarterly total assets for Sinovac Biotech?
Sinovac Biotech all-time high quarterly total assets is $16.75 B
What is Sinovac Biotech quarterly total assets year-on-year change?
Over the past year, SVA quarterly total assets has changed by -$761.04 M (-5.57%)